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Antimicrobial resistance is a natural biological phenomenon in their struggle for existence 
and represents a major health care issue, associated with high mortality and morbidity. 
The first cases of mass emergence of resistant strains were observed in the middle of the 
20th century, and since then cases of resistance have been reported all over the world, and 
in the last two decades even more frequently are reported multiple bacterial resistance. 
Factors that contribute to the development of bacteria resistance are abuse in the use of 
antibacterial agents, in humans or livestock, and releases of antibacterial agents into the 
environment. Moreover, the development of new effective antibiotics is decreasing, 
contrary to increasing the overall effort for the synthesis of new ones. Identification and 
reporting of  bacterial resistance, as well as monitoring of the use of antibiotics in the 
outpatient and inpatient setting, today is the obligation of all countries. 
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INTRODUCTION 
Antibiotic resistance was to occur when a drug loses its ability to inhibit bacterial 
growth effectively. Bacteria become ‘resistant’ and continue to multiply in the presence of 
therapeutic levels of the antibiotics (ZAMAN et al., 2017). Microorganisms generally acquire 
antibiotic resistance by genetic changes, but sometimes they do so by non-genetic mechanisms 
(MUNITA and ARIES, 2016). 
Non-genetic resistance occurs when certain bacterial strains temporarily change to L 
forms that lack most of their cell walls. For several generations, while the cell wall is lacking, 
these organisms are resistant to antibiotics that act on the cell walls. However, when they revert 
to producing cell walls they again become susceptible to the antibiotics (WALSH, 2000).  
Genetic resistance to antimicrobial agents develops genetic changes followed by natural 
selection. The Mollicutes of bacteria which genetically lack the cell walls, and   is not affected 
with the main classes of antimicrobial agents, such as -lactam, glycopeptides, and 
phosphomycin (CHREMOVA et al., 2016). 
Genetic resistance might be the chromosomal and extra-chromosomal. Chromosomal 
resistance can be spontaneous, which is very rare. Further, in most bacteria, mutations occur 
spontaneously at a rate of about 1 per 10 million to 10 billion organisms. Bacteria reproduce 
rapidly and among them there will always be a few mutants. If a mutant happens to be resistant 
to antibiotics in the environment, after a few generations, most survivors will be resistant to this 
antimicrobial agent. Antibiotics do not induce mutations, but they can create environments 
which could favor the survival of resistant mutant (WALSH, 2000). 
Bacterial resistance occurs due to the existence of extra-chromosomal genetic 
structures, such as plasmids and transposons, which can be transferred from bacteria to bacteria 
in the processes known as conjugation, transduction and transformation (COCULESCU, 2009). 
Bacteria conjugation is one of the main mechanisms whereby bacteria become resistant  to 
antibiotics. Therefore, the search for specific conjugation inhibitors is of  interest in the fight 
against the spread of antibiotic resistances (CABEZON et al., 2017). Conjugation is the transfer of 
DNA through a multi-step process requiring cell to cell contact via cell surface pili or adhesins. 
It is facilitated by the conjugative machinery which is encoded either by genes on autonomously 
replicating plasmids or by integrative conjugative elements in the chromosome (WINTERSDORFF 
et al., 2016). ARGs are in many cases associated with conjugative elements such as plasmids or 
transposons. β-lactam resistance genes are commonly located on plasmids and thus disseminate 
by inter- and intraspecies conjugation in the Enterobacteriaceae, Pseudomonas and 
Acinetobacter (LERMINIAUX and CAMERON, 2018). The transfer of plasmids in pathogens has led 
to the worldwide spread of numerous ARGs encoding resistance to β-lactams, quinolones, 
aminoglycosides, tetracyclines, sulfonamides, and many other drug classes (HUDDLESTON, 
2014). The free fragments of DNA, to the environment can be taken up and incorporated into the 
chromosome of a living bacterium to provide the recipient with new characteristics. This process 
is called bacterial transformation, and if the incorporated DNA contains genes that encode for 
resistance to an antibiotic, a previously susceptible bacterium can be "transformed" to now be 
resistant. In order for transformation to take place, several conditions have to be met. There must 
be DNA present in the extracellular environment; the recipient bacteria must be in a state of 
competence; and the translocated DNA must be stabilized, either by integration into the recipient 
genome, or by recircularisation in the case of plasmid DNA (WINTERSDORFF et al., 2016). 
Several clinically relevant antibiotic resistant pathogens are capable of DNA uptake and natural 
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transformation, including Acinetobacter, Haemophilus, Neisseria, Pseudomonas, 
Staphylococcus, and Streptococcus (LERMINIAUX and CAMERON, 2018). Bacteriophages play an 
important role in shaping the bacterial microbiome in any environment. Through specialized or 
generalized transduction, bacteriophages can transfer genes that are advantageous to their 
microbial hosts, in turn promoting their own survival and dissemination (MODI et al., 2013). The 
transferable DNA sequences range from chromosomal DNA to mobile genetic elements, such as 
plasmids, transposons and genomic islands. Recent studies found that over 70% of hospital fecal  
samples tested positive for bacteriophages containing ARGs (QUIROS et al., 2013), and hospital 
wastewaters were  contaminated with bacteriophages containing ARGs.  
In clinical practice, it is important that some bacteria could survive antibiotic therapy in 
a latent state. For example, some patients with Lyme borreliosis develop a chronic infection 
because of the ability of Borrelia to survive in the latent state. The persistence of Borrellia have 
been confirmed by isolation from clinical material after antibiotic therapy while in some other 
patients the therapy is successful only after repetition or prolonged use of antibiotics (VEINOVIC 
et al., 2013; VEINOVIC et al., 2015). 
Five mechanisms to resistance have been identified so far, and each of them involves 
the alteration of a different microbial structure. Resistance to antibiotics can be caused by five 
general mechanisms: 1) alteration of targets (antibiotics can no longer bind to the target); 2) 
alternation of membrane permeability; 3) development of enzymes (-lactamases exist in various 
bacteria and they are capable of breaking -lactam ring in penicillins); 4) alteration of enzymes; 
and 5) alteration of metabolic pathways (MC MANUS, 1997; SCHMIEDER and EDWARDS, 2012). 
Mechanisms of antibiotic resistance in bacteria are shown in Table 1. 
 

































Bacteria can develop resistance to antibiotics by mutations of existing genes (vertical 
evolution) or by acquiring new genes from other strains or species (horizontal gene transfer). The 
sharing of genes between bacteria by horizontal gene transfer occurs by many different 
mechanisms. Mobile genetic elements, including phages, plasmids and transposons mediate this 
transfer, and in some circumstances, the presence of low levels of the antibiotic in the 
environment is the key signal that promotes gene transfer (DZIDIC et al., 2008). 
 
Culture-independent study of resistance through metagenomics  
Many studies have identified the presence of antibiotic resistance genes (ARG) from a 
wide variety of ecological niches: soil, animals (especially edible animals, are sources of ARG 
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due to antibiotic use in agriculture), fecal pollution of water, human gut microbiomes. The 
presence of a resistance gene does not indicate if this is the source or sink of the resistance gene 
(FITZPATRICK et al., 2016). The soil is thought to be a substantial source of ARG, and it is 
thought that antibiotic producing microorganisms in soil are the source of resistance genes found 
in clinical pathogens (CANTON and COBO, 2009). 
The most of the bacterial species from environment have never been cultivated by 
conventional microbiology techniques. In this situation, a comprehensive analysis of bacterial 
communities requires the utilization of non-culture-based methods, which have been named 
metagenomics (GARMENDIA et al., 2012; BEJARANO et al., 2018). Functional metagenomics 
involve cloning and expression of DNA in a surrogate host with coupled activity-based 
screening. Sequence-based metagenomics involves extracting and random sequencing of 
deoxyribonucleic acid (DNA) directly from the environment. To date, 16S rDNA sequencing, 
metagenomics and metatranscriptomics are the three basic sequencing strategies used in the 
taxonomic identification and characterization of environment-related microbiomes. These 
sequencing strategies have used different next generation sequencing platforms for DNA and 
RNA sequence identification (CAO et al., 2017).  
Next generation sequencing (NGS) allows sequencing of the whole genome of 
numerous pathogens in one sequence run, either from bacterial isolates of (different) patients, or 
from multiple species present in patient material from one individual (metagenomics) 
(DEURENBERG et al., 2017). For NGS, there is no need for target specific primers, which are 
needed for tradicionally 16S rDNA sequencing. In a single run, the whole genome of a pathogen 
is sequenced at random. This approach provides greater sequence resolution than traditional 
methods by delivering a definitive catalog of genetic polymorphisms, particularly single-
nucleotide polymorphisms (SNPs). WGS also associates epidemiology to genome evolution, 
genome structure, pathogen biology and gene content; which provides insights to biological 
markers, such as antibiotic resistance and virulence factors (RAMANATHAN et al., 2017).  
The metagenomics sequences are then compared to known sequences to identify genes 
and/or mutations (SCHMIEDER and EDWARDS, 2012). The recent analysis of the human gut 
resistome by using functional metagenomics techniques demonstrated that human microbiota 
contains a large number of resistance elements. Several of them are distinct from those acquired 
by human pathogens through horizontal gene transfer (HGT) and probably constitute the 
intrinsic resistome of those microorganisms. However, the microbiota harbored as well genes 
coding for TEM-type, CblA, CfxA and CTX-M b-lactamases, which are classical resistance 
determinants disseminated by HGT. The presence of these genes suggests that they can be 
maintained in the gut microbiota in the absence of selection and indicates that human microbiota 
can be a reservoir for HGT-acquired resistance genes (GARMENDIA et al., 2012). The research 
according NESME et al. (2014) reported that soil metagenomes have the most diverse pool of 
antibiotic resistance gene of determinates. The most common types of resistances found in 
environmental metagenomes were efflux pumps and genes conferring resistance to vancomycin, 
tetracycline, or β-lactam antibiotics used in veterinary and human healthcare. The most prevalent 
resistance classes  found in the metagenome environments are: ABC class transporter system: 
bacitracin (bcr, bcr_mfs), RND class transporter (macab), tetracycline-specific efflux pump (tet 
efflux), penicilin-binding protein (pbp), class A and class B β-lactamases (blaA, blaB) and 
vancomycin resistance operon genes (vanA, vanB, vanC, vanD, vanE, vanG).   
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The conventional methods combining culture with molecular methods are enhancing 
efforts in resistance profiling. Functional metagenomics has become a vital tool for identifying 
genes that confer resistance to selected antibiotics in environmental samples (MCLAIN et al., 
2016). 
 
Mechanisms of resistence to antimicrobial agents in different bacteria 
Since the discovery and subsequent widespread use of antibiotics, a variety of Gram 
positive and Gram negative bacteria of human and animal origin have developed numerous 
mechanisms of antibiotic resistance (DZIDIC et al., 2008). In this review we are demonstrated 
mechanisms some of bacteria. 
Staphylococci, together with pneumococci and streptococci, are members of a group of 
invasive Gram-positive pathogens, known as the pyogenic cocci, which cause various 
suppurative or pus-forming diseases in humans and animals.  
When antibiotic resistance was first encountered among bacteria, including 
Staphylococcus aureus, it was believed to arise solely by mutation and selection. Spontaneous 





per cell in the laboratory, and it was assumed that analogous events had occurred in natural 
populations to produce resistant organisms. Indeed, resistance within the staphylococci to several 
therapeutically useful antibiotics, including streptomycin, rifampin, fusidic acid, and novobiocin, 
is thought to be derived by chromosomal mutation. A number of resistance determinants have 
been mapped on the S. aureus chromosome. In some cases, however, chromosomal point 
mutations, which lead to antibiotic resistance, can be deleterious to the organism, resulting in the 
creation of less virulent forms. The acquisition of new characters, without affecting the fitness of 
the bacteria to survive in their natural environment, would therefore be expected to occur over a 
substantial time span. In an evolutionary sense, then, the accumulation of chromosomal 
mutations would seem to be unsatisfactory as the sole explanation for the rapid emergence of 
multidrug resistant bacteria. The relatively minor role played by spontaneous mutation in the 
stridden appearance of antibiotic-resistant microorganisms was confirmed by the discovery of 
gene transfer and the demonstration that bacteria can acquire additional genetic material in the 
form of extrachromosomal or plasmid DNA. The existence of plasmid DNA molecules was 
suggested by the transfer of discrete genetic units of resistance between bacterial strains and the 
irreversible loss of such units from cells at relatively high frequencies. Resistance to 
antimicrobial agents in the staphylococci, as in the gram-negative bacteria, is due to the presence 
of plasmids that carry the genetic determinants of resistance (LYON and SKURRAY, 1987). 
Following the discovery of penicillin, it seemed that S. aureus infections were 
controllable; however, the resistance was short-lived. The discovery and introduction of 
methicillin in 1959 were thought to be a sure defense against the penicillinases, but the 
appearance of methicillin resistant S. aureus (MRSA) within just 3 years led inexorably to other 
multidrug resistant variants, and the acronym now denotes multidrug resistant S. aureus. MRSA 
infections can be very serious and are among the most frequently occurring of all antibiotic-
resistant threats. MRSA is resistant to penicillin-like -lactam antibiotics (SENGUPTA et al., 
2013).  
A number of drugs still retain activity against MRSA, including glycopeptides (e.g., 
vancomycin and teicoplanin), linezolid, tigecycline, daptomycin, and even some new β-lactams, 
such as ceftaroline and ceftobiprole (PEREZ et al., 2008). MRSA has shown outstanding 
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versatility within emerging and spreading in different epidemiological settings over time (in 
hospitals, the community, and, more recently, in animals). This connects the epidemiology of 
MRSA infections and creates a challenge for infection-control systems that focus only on health 
care–associated infections (HAIs) (ROSSOLINI et al., 2014; VENTOLA, 2015).  
Although MRSA is often associated with infection in hospitals, community-associated 
MRSA (CA-MRSA) often cause infections in healthy people living in the community, who have 
not been in hospital or had any medical procedures. CA-MRSA has most of the properties of 
MRSA, albeit with different mec gene clusters, and has acquired new pathogenicity genes, such 
as the gene encoding the cytotoxic Panton-Valentine leukocidin (DAVIES and DAVIES, 2010; DE 
LEO and CHAMBERS, 2009). These are regulated by defined signaling systems (PIDDOCK, 2006). 
Acinetobacter is a Gram-negative bacteria that causes pneumonia or bloodstream 
infections, especially in critically ill patients on mechanical 
ventilation. Some Acinetobacter species have become resistant to all or nearly all antibiotics, 
including carbapenems, which are often considered to be the drug of last resort (VENTOLA, 
2015). Mechanisms of antibiotic resistance of this organism include acquirement of β-
lactamases, up-regulation of multidrug efflux pumps, modification of aminoglycosides, 
permeability defects, and alteration of target sites (LEE et al., 2017). Inactivation of β-lactams by 
β-lactamases is a major antibiotic resistance mechanism in Acinetobacter baumannii. Recent 
studies according TRAGLIA et al., (2014) have  shown that A. baumannii has natural competence 
to incorporate exogenous DNA and its genome has foreign DNA at high  frequencies, implying 
frequent horizontal gene transfer in this pathogen (LEE et al., 2017). Some genes involved in cell 
division, including blhA, zipA, zapA, and ftsK, are associated with intrinsic β-lactam resistance in 
A. baumannii (KNIGHT et al., 2016). The very high genetic plasticity of A. baumannii allows an 
accumulation of resistance determinants that give rise to multidrug resistance at an alarming rate. 
The multidrug resistance in A. baumannii seems to result from both the accumulation of multiple 
mutations and the acquisition of resistance genes from other bacterial genera, with the latter 
occurring by a variety of mechanisms, including the transfer of plasmids, transposons, and 
integrons, sometimes leading to the formation of clusters of resistance genes termed resistance 
islands (POIREL et al., 2011). 
Tuberculosis (TB) infections are treatable and curable with available of first-line drugs, such as 
isoniazid or rifampicin; however, in some cases, Mycobacterium tuberculosis can be resistant to 
one or more of these first-line drugs. The careless use of antibiotics has created a selective 
pressure pushing a rapid evolution of M. tuberculosis, marching from mono-drug resistant to the 
multidrug resistant (MDR), extensively drug resistant (XDR), and eventually totally drug 
resistant (TDR), through sequential accumulation of resistance mutations (FONSEKA et al., 2015). 
Because the treatment of drug-resistant TB can be a complex, requiring longer treatment periods 
and more expensive drugs that often have more side effects. Extensively of resistant TB (XDR-
TB) is resistant to most TB drugs, including isoniazid and rifampicin, any fluoroquinolones, and 
any of the three second-line injectable drugs (i.e., amikacin, kanamycin, and capreomycin); 
Therefore, fewer treatment options are available for patients with XDR-TB, and the drugs that 
are available are much less effective (GOLKAR et al., 2014). 
The treatment of MDR-TB patients commonly lasts for 2 years or longer and relies on 
the use of second-line drugs (such as fluoroquinolones and injectable aminoglycosides) that are 
less effective, more toxic, and far more costly. The prognosis of patients infected with XDR-TB 
is extremely poor and the spread of these strains raises the possibility of the return to a pre-
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antibiotic era (GAGNEUX et al., 2003). The de novo emergence of drug resistance in an individual 
patient can occur as a result of low adherence to treatment, inadequacy of the drug regimen (e.g., 
wrong antibiotic choices or dosages, poor drug quality), and patient-dependent 
pharmacodynamic and pharmacokinetic properties of the drugs administered. In recent years, 
several determinants of acquired resistance to the drugs commonly used in the treatment of TB 
have been elucidated (FONSECA et al., 2015; GANDHI et al., 2010).  
The mechanisms and pathways that result in the emergence and subsequent fixation of 
resistant strains of M. tuberculosis are not fully understood and recent studies suggest that they 
are much more complex than initially thought (FONSECA et al., 2015). In M. tuberculosis, 
horizontal transfer of drug resistance genes has not been reported; but resistance mostly arises 
from gene mutations. The genes involved in acquired drug resistance in M. tuberculosis are: 
katG (encoded catalase peroxidase), ndh (NADH dehidrogenase), ethA (flavin monooxygenase), 
tlyA (rRNA methyltransferase), folC (dihydrofolate synthase) and others. The mutations in these 
genes lead to increased gene expression or to enzymatic activities which rescue mycobacteria 
cells from the activity of antimicrobial agents (NGUYEN, 2016). 
Furthermore, there are indications that the acquisition of clinically significant resistance 
to certain drugs might be a stepwise process that often involves an initial low-level mutation that 
acts as a gateway for high-level resistance. The clinical implications of these findings should be 
investigated (FONSECA et al., 2015). 
Pseudomonas aeruginosa is a common cause of community-acquired and nosocomial 
acquired pneumonia and is responsible for 10% of all hospital-acquired infections worldwide 
(MATTA et al., 2018). The development of resistance of P. aeruginosa to antibiotics is increasing 
globally due to the overuse of antibiotics (YAYAN et al., 2015). Epidemiological outcome studies 
have shown that infections caused by drug-resistant P. aeruginosa are associated with significant 
increases in morbidity, mortality, need for surgical intervention, length of hospital stay and 
chronic care, and overall cost of treating the infection (GASINK et al., 2006; LISTER et al., 2009). 
P. aeruginosa can develop resistance to antibacterials either through the acquisition of resistance 
genes on mobile genetic elements (i.e., plasmids) or through mutational processes that alter the 
expression and/or function of chromosomally encoded mechanisms (LISTER et al., 2009).  
The resistance of P. aeruginosa to fuoroquinolone (FQs) is mainly due to: (1) the point 
mutations in the DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE) genes, (2) 
the presence of transferable plasmid-mediated quinolone resistance (PMQR) determinants, and 
(3) mutations in genes regulating the expression of efflux pumps and decreased expression of 
outer membrane porins (YANG et al., 2015). Imported resistance of P. aeruginosa to 
aminoglycosides most commonly includes enzymatic inactivation of the drug molecule through 
chemical modification. In addition to the variety of aminoglycoside-modifying enzymes, high-
level resistance to multiple aminoglycosides can be associated with methylation of the 16S 
rRNA. This mechanism was first reported for P. aeruginosa in 1993, and the methylase encoding 
gene was designated as rmtA. There are currently five characterized ribosomal methyltransferase 
enzymes (RmtA, RmtB, RmtC, RmtD, and ArmA) that have been found worldwide among 
clinical isolates of P. aeruginosa and Enterobacteriaceae (LISTER et al., 2009). The P. 
aeruginosa strains possess the ampC gene for the inducible chromosomal lactamase. 
However, the spontaneous mutations in regulatory gene ampR, can increase the expression of 
chromosomal -lactamase genes. These mutants will be selected under the pressure of antibiotic 
usage, especially where monotherapy is employed (RAMANATHAN et al., 2017).  
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Bacterial multidrag resistence proteins 
Lactococcus lactis is a lactic acid bacteria (LAB) widely used as a starter culture in 
dairy industry. Although lactococci have acquired the „Generally Regarded As Safe―(GRAS) 
status, many investigators have speculated that lactococci as well as other LAB may act as 
reservoirs of antibiotic resistance genes. In order to prevent the spread of these genes, the studies 
on the antibiotic resistance mechanisms and multidrug resistance transporters within them, are of 
the great importance for lactococci intended for use in the food industry (BOLHUIS et al., 1997). 
Bacterial multidrug resistance (MDR) proteins play an important role in the resistance of 
bacterial cells to various cytotoxic structurally unrelated compounds such as heavy metals, 
organic solvents, dyes, disinfectants, and antibiotics. The MDR transporters have been broadly 
classified into two major classes: the ATP-binding cassette (ABC) primary transporters, which 
use the hydrolysis of ATP as energy source for transport and the secondary transporters, driven 
by a proton or sodium motive force (pmf or smf). Studies on bacterial MDR transporters are 
becoming highly relevant during the last years since the MDR activities have been associated 
with the ongoing emergence of antibiotic resistance in pathogenic bacteria. Although L. lactis is 
considered to be non-pathogenic and safe to use in starter cultures for cheese production, 
previous results showed the broad antibiotic specificity of LmrP, LmrA, LmrCD and the most 
recently described CmbT MDR transporters present in L. lactis. MDR transporter could be 
associated with the mobile genetic elements implicating the possible transfer of the related genes 
to other bacteria present in food or the gastrointestinal tract, and as the final consequence, a 
serious threat to the efficacy of valuable antibiotics. Both the pmf-driven and the ABC 
transporters in L. lactis mediate resistance to toxic hydrophobic compounds, mainly cations and 
antibiotics, although several lactic acid bacteria also possess MDR transporters that mediate the 
extrusion of anionic antimicrobial compounds possibly conferring resistance to cholate. CmbT 
multidrug resistance protein of L. lactis contributes to extruding the structurally, chemically, and 
pharmacologically diverse range of substrates out of bacterial cells. This function of CmbT may 
result in the failure of antibiotic therapy. Homology model of CmbT protein was constructed and 
further optimized. The 3D-QSAR (Quantitative structure-activity relationships) model predictive 
potential was proved by use of leave-one-out cross validation of the training set (Q2: 0.69, 
R2Observed vs: Predicted: 0:918; RMSEE: 0.193) and verification set (R2Observed vs: 
Predicted: 0:704; RMSEP: 0.289) (LUBELSKI et al., 2006). The results showed that high CmbT 
affinities to ethidium, sulbactam, and sulfathiazole could be related to the absence of significant 
unfavorable interactions. In contrast, the presence of specific unfavorable interaction between 
two hydrogen bond donor groups in bacitracin, apramycin, novobiocin, vancomycin, kanamycin, 
gentamycin, and tobramycin is found to be the main reason for their lower CmbT affinities. In 
addition, membrane position of the CmbT binding site and positive correlation between 
substrates lipophilicity (log DpH 5.0) and CmbT affinity strongly indicates that CmbT 
recognizes its substrates within the membrane (FILIPIC et al., 2014; FILIPIC et al., 2013). 
 
Natural products from aromatic and medical plants as antimicrobial agens 
In the last 10 years, knowledge and expertise in biosynthetic capacity and secondary 
metabolites of medicinal and aromatic plants has been acquired in Europe and the world. 
According to World Health Organization (WHO), medicinal plants would be the best source in 
bioactive compounds to obtain a variety of drugs and alternative antibiotics. The therapeutic 
effect of essential oils from medical and aromatic plants is related to the content of many 
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biologically active compounds, including naphthoquinones, flavonoids, terpenoids and phenols 
(SHARMA et al., 2009). These constituents have a wide range of pharmaceutical activities, 
including anti-inflammatory, antimutagenic, antiviral and antibacterial activities (VUKOVIC 
GACIC et al., 2006). Also, recent investigations have demonstrated that nanoparticles with 
essential oils have significant antimicrobial potential against multidrug resistant pathogens 
(CHOUHAN et al., 2017). The significant antimicrobial activity and chemical constituents of 
essential oils from Lamiaceae species: Mentha piperita (DAMJANOVIC-VRATNICA et al., 2016), 
Thymus vulgaris (DAMJANOVIC-VRATNICA et al., 2015) and Satureja montana (DAMJANOVIC-
VRATNICA et al., 2011; DAMJANOVIC-VRATNICA et al.,2015a) was also reported. According to the 
general literature Lavandula angustifolia has been used as an antibiotic and in combination with 
Pelargonium graveolens and Melaleuca alternifolia demonstrated activity against MRSA (DE 
RAPPER et al., 2013). Further essential oils from Eucalyptus globulus and Melaleuca alternifolia 
have effects against Pseudomonas aeruginosa (SAMBYA et al., 2017). The volatile oil extracts 
from Cinnamomum verum (Lauraceae), Syzygium aromaticum (Myrtaceae), Ocimum 
gratissimum and Ocimum basilicum (Lamiaceae) have significant antimicrobial effects against 
Acinetobacter baumannii, one of the most important drug resistant pathogens worldwide 
(INTORASOOT et al., 2017). The recent investigation demonstrated that essential oil isolated from 
leaves of Tetradenia riparia and the pure compound 6,7-dehydroroyleanone display good 
activity against Mycobacterium tuberculosis clinical isolates, including MDR isolates, with low 
cytotoxicity to murine macrophages. The 6,7-dehydroroyleanone compound is a potential 
candidate for anti-TB drug (BALDIN et al., 2018). 
The mechanisms of action of essential oils against pathogen microorganisms are 
different: induced leakage of the cell, loss of membrane integrity, disruption of membrane, cell 
wall damage (CHOUHAN et al., 2017). Essential oils from plant would be promising antimicrobial 
agents for further treatment of human pathogens, including multidrug resistant bacteria. 
 
CONCLUSIONS 
Bacterial resistance to antibiotics has been reported in all parts of the world and it is 
relatively prevalent. Despite the measures of the WHO and the management of public health 
institutions, the use of antibiotics in agriculture, veterinary medicine and health care is still 
relatively high. Treatments for bacterial infections become more intense every day, leading to an 
increased resistance. Demand for new antibiotics, bioactive molecules derived from aromatic and 
medical plants increase the chances of creating new antibacterial therapies. 
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Antibiotska rezistencija je prirodni fenomen i izazov povezan sa visokom stopom morbiditeta i 
mortaliteta širom sveta. U poslednjih deset godina pojava multirezistentnih bakterija predstavlja 
ozbiljan problem u javnom zdravstvu. Osnovni faktori koji doprinose pojavi antimikrobne 
rezistencije su, zloupotreba u korišćenju antibakterijskih agenasa u medicini i poljoprivredi, a 
takoĊe, ispuštanje antimikrobnih agenasa u životnu sredinu. TakoĊe, procesi razvoja novih 
efikasnih antibiotika nisu bili uspešni u meri u kojoj se oĉekivalo. Ovaj rad razmatra mehanizme 
otpornosti na antibiotike i metode za njihovu detekciju, kroz primere rezistencije bakterija, kao 
što su Staphylococcus aureus, Micobacterium tuberculosis,  Pseudomonas aeruginosa i 
Acinetobacter.TakoĊe, dat je kratak prikaz o bioaktivnim komponentama poreklom iz 
medicinskih i aromatiĉnih biljaka, kao nove linije antimikrobne terapije.  
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